Josh Eizen
Equibles does not estimate personal net worth.
About Josh Eizen
Josh Eizen is recorded as COO at AN2 Therapeutics, Inc. (ANTX). The proxy statement of AN2 Therapeutics, Inc. reports total compensation of $807,080 for Josh Eizen in fiscal 2025, including a base salary of $450,000. Disclosed compensation is on record for 3 fiscal years. AN2 Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at AN2 Therapeutics, Inc. includes Eric Easom (CEO and Board Member), Lucy Day (CFO and Chief Accounting Officer), Joshua Eizen (COO and General Counsel) and 7 others.
Affiliation history
-
Current
Company network
Leadership on record at AN2 Therapeutics, Inc.
- Eric Easom CEO, Board Member
- Lucy Day CFO, Chief Accounting Officer
- Joshua Eizen COO, General Counsel
- Sarah Williams Chief Accounting Officer
- Gilbert Lynn Marks Board Member
- Joseph Zakrzewski Board Member
- Kabeer Aziz Board Member
- Margaret (Maggie) M. FitzPatrick Board Member
- Margaret FitzPatrick Board Member
- Melvin Spigelman Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | AN2 Therapeutics, Inc. (ANTX) | Chief Legal Officer and Chief Operating Officer | $450,000 | $807,080 |
| 2024 | AN2 Therapeutics, Inc. (ANTX) | Chief Legal Officer and Chief Operating Officer | $435,375 | $1,057,350 |
| 2023 | AN2 Therapeutics, Inc. (ANTX) | Chief Legal Officer and Chief Operating Officer | $410,000 | $1,147,944 |
Recent activity
No call appearances or filed executive changes recorded yet.